JPS6299384A - （ｃｈ↓３）↓３ｎｂｈ↓２ｃｏｏｃｈ↓３を含む脂血低下剤 - Google Patents
（ｃｈ↓３）↓３ｎｂｈ↓２ｃｏｏｃｈ↓３を含む脂血低下剤Info
- Publication number
- JPS6299384A JPS6299384A JP60238534A JP23853485A JPS6299384A JP S6299384 A JPS6299384 A JP S6299384A JP 60238534 A JP60238534 A JP 60238534A JP 23853485 A JP23853485 A JP 23853485A JP S6299384 A JPS6299384 A JP S6299384A
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- methyl
- haloalkyl
- benzyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Amino acid boron analogue ester Chemical class 0.000 title claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 claims description 9
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 125000001188 haloalkyl group Chemical group 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 229910000085 borane Inorganic materials 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- KOXIGEBRUGYXFD-UHFFFAOYSA-N boranylformic acid Chemical compound BC(O)=O KOXIGEBRUGYXFD-UHFFFAOYSA-N 0.000 claims description 5
- KUVACXWWIKEMLH-UHFFFAOYSA-N carboxyboron Chemical compound [B]C(O)=O KUVACXWWIKEMLH-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 125000005270 trialkylamine group Chemical group 0.000 claims description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 4
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 230000003197 catalytic effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 description 20
- 230000000694 effects Effects 0.000 description 7
- 229910052796 boron Inorganic materials 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical group CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 150000001638 boron Chemical class 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010015719 Exsanguination Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- RIFGGBKCDHRFFC-UHFFFAOYSA-N CN(C)C.BC(=O)OC Chemical compound CN(C)C.BC(=O)OC RIFGGBKCDHRFFC-UHFFFAOYSA-N 0.000 description 1
- LQYLGZUVSVCTFE-UHFFFAOYSA-N CN.BC(=O)OC Chemical compound CN.BC(=O)OC LQYLGZUVSVCTFE-UHFFFAOYSA-N 0.000 description 1
- VNSPWNGVJHHVDT-UHFFFAOYSA-N CNC.BC(=O)OC Chemical compound CNC.BC(=O)OC VNSPWNGVJHHVDT-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- DSVPTPXKGOQDDQ-UHFFFAOYSA-N N.BC(=O)OC Chemical compound N.BC(=O)OC DSVPTPXKGOQDDQ-UHFFFAOYSA-N 0.000 description 1
- QIGLEZOOSVEDBK-UHFFFAOYSA-N NBC#N Chemical compound NBC#N QIGLEZOOSVEDBK-UHFFFAOYSA-N 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- MUTDNIUYABKXLN-UHFFFAOYSA-N azane;boranylformic acid Chemical compound [NH4+].BC([O-])=O MUTDNIUYABKXLN-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical group CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical group CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000006138 lithiation reaction Methods 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- OTDVRMNOBRGCJD-UHFFFAOYSA-N methyl boranylformate Chemical compound BC(=O)OC OTDVRMNOBRGCJD-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- FIAFUQMPZJWCLV-UHFFFAOYSA-N suramin Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(NC(=O)C3=CC=C(C(=C3)NC(=O)C=3C=C(NC(=O)NC=4C=C(C=CC=4)C(=O)NC=4C(=CC=C(C=4)C(=O)NC=4C5=C(C=C(C=C5C(=CC=4)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C)C=CC=3)C)=CC=C(S(O)(=O)=O)C2=C1 FIAFUQMPZJWCLV-UHFFFAOYSA-N 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60238534A JPS6299384A (ja) | 1984-10-25 | 1985-10-24 | （ｃｈ↓３）↓３ｎｂｈ↓２ｃｏｏｃｈ↓３を含む脂血低下剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/664,647 US4647555A (en) | 1984-10-25 | 1984-10-25 | Esters of boron analogues of amino acids |
| JP60238534A JPS6299384A (ja) | 1984-10-25 | 1985-10-24 | （ｃｈ↓３）↓３ｎｂｈ↓２ｃｏｏｃｈ↓３を含む脂血低下剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6299384A true JPS6299384A (ja) | 1987-05-08 |
| JPH0159249B2 JPH0159249B2 (enrdf_load_stackoverflow) | 1989-12-15 |
Family
ID=26533750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60238534A Granted JPS6299384A (ja) | 1984-10-25 | 1985-10-24 | （ｃｈ↓３）↓３ｎｂｈ↓２ｃｏｏｃｈ↓３を含む脂血低下剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6299384A (enrdf_load_stackoverflow) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57145886A (en) * | 1979-12-21 | 1982-09-09 | Deyuuku Univ Inc | Novel amine-carboxyborane, manufacture and anticancer and antihyperlipemic comprising same |
-
1985
- 1985-10-24 JP JP60238534A patent/JPS6299384A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57145886A (en) * | 1979-12-21 | 1982-09-09 | Deyuuku Univ Inc | Novel amine-carboxyborane, manufacture and anticancer and antihyperlipemic comprising same |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0159249B2 (enrdf_load_stackoverflow) | 1989-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH02138238A (ja) | ベンジリデン−およびシンナミリデン−マロンニトリル誘導体およびその製法 | |
| FR2733750A1 (fr) | Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique | |
| US4647555A (en) | Esters of boron analogues of amino acids | |
| JPH01213268A (ja) | １‐アルキル‐５‐ニトロイミダゾールの製造方法 | |
| JPS6299384A (ja) | （ｃｈ↓３）↓３ｎｂｈ↓２ｃｏｏｃｈ↓３を含む脂血低下剤 | |
| CA1070306A (en) | Nicotinoylaminotriazine derivatives | |
| US4275068A (en) | Lipid lowering alkylene glycols and ester derivatives thereof | |
| JPS585181B2 (ja) | アルアルキルアミンノセイホウ | |
| JPS61145174A (ja) | 新規な光学活性エポキシプロピオン酸エステル誘導体の製造法 | |
| JPH0144708B2 (enrdf_load_stackoverflow) | ||
| JPS63264490A (ja) | アミンボランエステルの製造方法 | |
| JPH01132572A (ja) | Ｎ−フッ化スルホンアミド、その製造方法及びその用途 | |
| CA1076577A (en) | Process for preparing hydrazinopyridazine derivatives | |
| JPS632935A (ja) | 光学活性アルコ−ル類の製造方法 | |
| JPS5838436B2 (ja) | １ ２− ジアルキルケトン−グリセリン −３− ホスフアタイド ノ セイホウ | |
| RU2043341C1 (ru) | Этиловый и 3-(n,n-диметиламино)-2,2-диметилпропиловый диэфир 2,5-диметил-4-(3-нитрофенил)-1,4-дигидропиридин-3,5-дикарбоновой кислоты гидрохлорид, обладающий пролонгированным антигипертензивным эффектом | |
| JPH09255668A (ja) | ビスオキサゾリン類の製造方法 | |
| JPS5930704B2 (ja) | 新規１，４−ジヒドロピリジン誘導体の製法 | |
| US5912380A (en) | Methoxycinnamyloxy salycilate and preparation thereof | |
| US3897465A (en) | Ethyl beta-(N-methylfurfurylamino) propionate | |
| JPS5921671A (ja) | ２‐メチルベンゾイミダゾール誘導体及びこれを含有する殺虫剤 | |
| JPH0247992B2 (ja) | Benzofuenonn22karubameetojudotai | |
| JPS6032783A (ja) | 含フッ素クマリン類 | |
| JPH03133958A (ja) | 光学活性ピリジルカルビノールの製造方法 | |
| JPS6169781A (ja) | トリ有機錫シラトラン誘導体の製造法 |